Bonnie Ramsey
Pediatrics / Pediatric Pulmonology
Credentials: · ·
History
Pediatric Pulmonology
Pediatrics
Research
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation
New England Journal of Medicine · 2011 · First of 20 authors · Corresponding · 1,787 citations
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
New England Journal of Medicine · 2019 · 1,774 citations
Pathophysiology and management of pulmonary infections in cystic fibrosis
Review · American Journal of Respiratory and Critical Care Medicine · 2003 · Last of 3 authors · 1,220 citations
- RG
38 papers
28 papers · 1 as a fellow
- DW
23 papers
- GR
23 papers
23 papers
19 papers
18 papers
17 papers
Grants
- 2010–2025
Center for Cystic Fibrosis Translational Research in the Post-CFTR Modulator Era
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Contact PI · $14.4M · Seattle Children's Hospital
- 2018–2024
Accelerate Cellular Immunotherapy Development for Treatment of Life-Threatening Childhood Disorders
National Center for Advancing Translational Sciences · U01
PI · $7.1M · Seattle Children's Hospital
- 2013–2021
OPTIMIZE - CCC - Lead Application
National Heart, Lung, and Blood Institute · U01
Contact PI · $6.6M · Seattle Children's Hospital
- 2012–2017
Baby Observational and Nutritional Study of Cystic Fibrosis
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.6M · Seattle Children's Hospital
Clinical trials
- 2020–2027
Principal investigator · Recruiting
Sonya Heltshe
- 2014–2018
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Principal investigator · Completed · Phase 3
Bonnie Ramsey
- 2009–2012
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
Principal investigator · Completed · Phase 3
Vertex Pharmaceuticals Incorporated
- 2004–2009
Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
Principal investigator · Completed · Phase 2
Seattle Children's Hospital